Dermavant presents ADORING 3 LTE final data on complete skin clearance and treatment-free interval for Vtama® (tapinarof) cream, 1% in adults and children as young as two years old with atopic dermatitis at the 44th Annual Fall Clini...
参考来源:‘ Dermavant announces FDA acceptance of supplemental new drug application (sNDA) for VTAMA (tapinarof) cream, 1% for the treatment of atopic dermatitis in adults and children 2 year of age and older ’,新闻发布。Dermavant Sciences;2024年4月29日发布。 注:本文旨在介绍医药健康研究,不...
2024年5月6日讯/香港登越药业Dengyue/--Dermavant Sciences 今天在一份新闻稿中宣布,FDA 已接受1%的tapinarof (Vtama) 乳霜的补充新药申请(sNDA),该药可用于成人和 2 岁及以上儿童特应性皮炎(AD)的局部治疗。 AD,也称为湿疹,是最常见的炎症性皮肤病之一,会导致剧烈瘙痒、发红和刺激。它影响着美国数以百万...
原始出处: Tapinarof cream 1% once daily: Significant efficacy in the treatment of moderate to severe atopic dermatitis in adults and children down to 2 years of age in the pivotal phase 3 ADORING trials. J Am Acad Dermat...
参考来源:FDA Approves Dermavant’s Vtama® (tapinarof) cream, 1% for the treatment of plaque psoriasis in adults: first topical novel chemical entity launched for psoriasis in the U.S. in 25 years.新闻发布,Dermavant Sciences;2022年5月24日。2022年5月25日访问。
参考文献:Lebwohl MG, Gold LS, Strober B, et al. Phase 3 trials of tapinarof cream for plaque psoriasis[J]. New England Journal of Medicine,2021,385:2219-2229. 世界医药里程碑系列①-茶和咖啡的神奇作用 世界医药里程碑系列②-世界上最早的疫苗 ...
参考来源:FDA Approves Dermavant’s Vtama® (tapinarof) cream, 1% for the treatment of plaque psoriasis in adults: first topical novel chemical entity launched for psoriasis in the U.S. in 25 years.新闻发布,Dermavant Sciences;2022年5月24日。2022年5月25日访问。
参考来源:'Dermavant Reports Positive Topline Results from ADORING 2 Atopic Dermatitis Phase 3 Trial of VTAMA® (tapinarof) Cream, 1% Once Daily in Adults and Children as Young as 2 Years Old’,新闻发布。Dermavant Sciences;2023年3月15日发布。
参考文献:Lebwohl MG, Gold LS, Strober B, et al. Phase 3 trials of tapinarof cream for plaque psoriasis[J]. New England Journal of Medicine,2021,385:2219-2229. 推荐 世界医药里程碑系列①-茶和咖啡的神奇作用 世界医药里程碑系列②-世界上最早的疫苗 ...
参考来源:‘Dermavant Reports Positive Topline Results from ADORING 2 Atopic Dermatitis Phase 3 Trial of VTAMA® (tapinarof) Cream, 1% Once Daily in Adults and Children as Young as 2 Years Old’,新闻发布。Dermavant Sciences;2023年3月15日发布。